These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26249353)

  • 1. Three-dimensional structure of the human breast cancer resistance protein (BCRP/ABCG2) in an inward-facing conformation.
    Rosenberg MF; Bikadi Z; Hazai E; Starborg T; Kelley L; Chayen NE; Ford RC; Mao Q
    Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1725-35. PubMed ID: 26249353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone.
    Rosenberg MF; Bikadi Z; Chan J; Liu X; Ni Z; Cai X; Ford RC; Mao Q
    Structure; 2010 Mar; 18(4):482-93. PubMed ID: 20399185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D cryo-electron reconstruction of BmrA, a bacterial multidrug ABC transporter in an inward-facing conformation and in a lipidic environment.
    Fribourg PF; Chami M; Sorzano CO; Gubellini F; Marabini R; Marco S; Jault JM; Lévy D
    J Mol Biol; 2014 May; 426(10):2059-69. PubMed ID: 24630999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional structure by cryo-electron microscopy of YvcC, an homodimeric ATP-binding cassette transporter from Bacillus subtilis.
    Chami M; Steinfels E; Orelle C; Jault JM; Di Pietro A; Rigaud JL; Marco S
    J Mol Biol; 2002 Feb; 315(5):1075-85. PubMed ID: 11827477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.
    Ni Z; Bikadi Z; Cai X; Rosenberg MF; Mao Q
    Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1100-9. PubMed ID: 20739628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states.
    Manolaridis I; Jackson SM; Taylor NMI; Kowal J; Stahlberg H; Locher KP
    Nature; 2018 Nov; 563(7731):426-430. PubMed ID: 30405239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The linker region of breast cancer resistance protein ABCG2 is critical for coupling of ATP-dependent drug transport.
    Macalou S; Robey RW; Jabor Gozzi G; Shukla S; Grosjean I; Hegedus T; Ambudkar SV; Bates SE; Di Pietro A
    Cell Mol Life Sci; 2016 May; 73(9):1927-37. PubMed ID: 26708291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
    Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
    Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
    Daood M; Tsai C; Ahdab-Barmada M; Watchko JF
    Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the human multidrug transporter ABCG2.
    Taylor NMI; Manolaridis I; Jackson SM; Kowal J; Stahlberg H; Locher KP
    Nature; 2017 Jun; 546(7659):504-509. PubMed ID: 28554189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib.
    Dohse M; Scharenberg C; Shukla S; Robey RW; Volkmann T; Deeken JF; Brendel C; Ambudkar SV; Neubauer A; Bates SE
    Drug Metab Dispos; 2010 Aug; 38(8):1371-80. PubMed ID: 20423956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2.
    Xu J; Liu Y; Yang Y; Bates S; Zhang JT
    J Biol Chem; 2004 May; 279(19):19781-9. PubMed ID: 15001581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allocrite Sensing and Binding by the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1).
    Xu Y; Egido E; Li-Blatter X; Müller R; Merino G; Bernèche S; Seelig A
    Biochemistry; 2015 Oct; 54(40):6195-206. PubMed ID: 26381710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.
    Han B; Zhang JT
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):31-42. PubMed ID: 14754410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationships in ABCG2: insights from molecular dynamics simulations and molecular docking studies.
    Ferreira RJ; Bonito CA; Cordeiro MNDS; Ferreira MU; Dos Santos DJVA
    Sci Rep; 2017 Nov; 7(1):15534. PubMed ID: 29138424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity.
    Ni Z; Bikadi Z; Shuster DL; Zhao C; Rosenberg MF; Mao Q
    Biochemistry; 2011 Sep; 50(37):8057-66. PubMed ID: 21854076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D structure of the transporter ABCG2-What's new?
    Eckenstaler R; Benndorf RA
    Br J Pharmacol; 2020 Apr; 177(7):1485-1496. PubMed ID: 31985041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.
    Hou YX; Li CZ; Palaniyandi K; Magtibay PM; Homolya L; Sarkadi B; Chang XB
    Biochemistry; 2009 Sep; 48(38):9122-31. PubMed ID: 19691360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.